| Marc Galland, DO | |
|
700 Highlander Blvd Ste 415, Arlington, TX 76015-4346 | |
| (817) 516-8811 | |
| (817) 516-8444 |
| Full Name | Marc Galland |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 700 Highlander Blvd Ste 415, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134440936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | Q1605 (Texas) | Primary |
| Entity Name | Arcadia Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568800266 PECOS PAC ID: 8325280829 Enrollment ID: O20130813000631 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Champion Anesthesia Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649676024 PECOS PAC ID: 7113231358 Enrollment ID: O20150803000277 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Td Anesthesia Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891166039 PECOS PAC ID: 2163729336 Enrollment ID: O20160404000311 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Arcadia Anesthesia Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063867463 PECOS PAC ID: 8022309772 Enrollment ID: O20160628000139 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Vertex Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487106175 PECOS PAC ID: 1052692324 Enrollment ID: O20161228000298 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Texas Anesthesia Partners, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144673468 PECOS PAC ID: 3870879828 Enrollment ID: O20170406000406 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Marc Daniel Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497263750 PECOS PAC ID: 1052672086 Enrollment ID: O20180307001922 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20180608000439 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20180905000794 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | Rpm Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669022786 PECOS PAC ID: 6901238443 Enrollment ID: O20191121000648 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Entity Name | 360 Pain And Spine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821611153 PECOS PAC ID: 6103247598 Enrollment ID: O20200611001534 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc Galland, DO 700 Highlander Blvd Ste 415, Arlington, TX 76015-4346 Ph: (817) 516-8811 | Marc Galland, DO 700 Highlander Blvd Ste 415, Arlington, TX 76015-4346 Ph: (817) 516-8811 |
News Archive
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan.
› Verified 9 days ago
Don Escarzega-phan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1119 W Randol Mill Rd, Arlington, TX 76012 Phone: 817-860-2700 Fax: 817-860-2704 | |
Lakiesha Kitchen Crawford, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 W Arbrook Blvd, Ste 130, Arlington, TX 76014 Phone: 855-549-7246 Fax: 817-803-4125 | |
Jason Matthew Voigt, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 East Lamar Blvd, Arlington, TX 76006 Phone: 214-207-0862 | |
Mark A. Morgan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Highlander Blvd, Suite 415, Arlington, TX 76015 Phone: 817-516-8811 Fax: 817-516-8444 | |
Felicia Mcleod Abram, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1903 Autry Ct, Arlington, TX 76017 Phone: 817-417-5688 Fax: 817-290-0508 | |
Dr. Charles Creed Coffee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 E. Lamar, 400, Arlington, TX 76006 Phone: 888-804-3000 Fax: 817-334-0235 |